Increased Breakthrough Rates Of South African Variant From Pfizer-BioNTech Vaccine - An Israeli Study | drbeen
Author declares no conflict of interest.
Get free trial
with access to all our lectures
DrBeen Logo

no credit card required

My Notes

Become a member to create study notes.
Sign up for free trial
Increased Breakthrough Rates Of South African Variant From Pfizer-BioNTech Vaccine - An Israeli Study Duration: 1110
Microbiology / Virology

Learning Objectives

A study from Israel reviewed the type of variant infecting vaccinated individuals during the dosage schedule and after the complete vaccination. 

In this video we will discuss the following topics:

  1. Study design.
  2. The SARS-COV-2 variant that infected vaccinated individuals while they were not fully protected.
  3. The SARS-COV-2 variant that infected fully protected vaccinated individuals. That is the variant infecting vaccinated individuals after two weeks of the second dose.
  4. We will also discuss a tweet by the researchers clarifying that no infection was observed by any of the SARS-COV-2 variants after the third week from the second dose of the Pfizer-BioNTech vaccine.

Instructor

Dr. Mobeen Syed

Dr. Mobeen Syed

Mobeen Syed M.D, MS Graduated from King Edward Medical University. Entrepreneur, Medical Educator, CEO and founder of Drbeen corp.


Videos in this series